Champion Safe Continues to Build Sales Momentum as Sports Inc. Dealers Shift to Enhanced Challenger 20 Safe Model
Globenewswire· 2026-02-26 13:30
American Rebel Holdings Inc Champion Safe Continues to Build Sales Momentum as Sports Inc. Dealers Shift to Enhanced Challenger 20 Safe Model American Rebel Holdings Inc Champion showcased its Trophy Series Independent retailers place spring orders in Phoenix as Challenger 20 replaces the Sports Inc–exclusive Model T with an integrated 120V outlet and refreshed black-chrome hardware—built with American-made steel Provo, UT, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Champion Safe Company (championsafe.com), ...
PennantPark Floating Rate Capital Ltd. Prices Public Offering of $200 Million 6.75% Notes
Globenewswire· 2026-02-26 13:28
MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the “Company”) (NYSE: PFLT) today announced that it has priced an underwritten public offering of $200 million aggregate principal amount of its 6.75% notes due 2029 (the “Notes”). The Notes will mature on March 4, 2029 and may be redeemed in whole or in part at the Company’s option at any time at par plus a “make-whole” premium, if applicable, provided that the Notes may be redeemed at par three months prior to their maturity. ...
Primech Holdings Secures Approximately US$5.02 Million in Multi-Year Residential Cleaning Contracts, Expanding Recurring Revenue Base
Globenewswire· 2026-02-26 13:27
Strengthening Recurring Revenue Base Through Multiple Multi-Year Residential Contract Awards.SINGAPORE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Primech Holdings Limited (Nasdaq: PMEC), an established technology-driven facility services provider servicing public and private sectors primarily in Singapore, today announced that its subsidiary Primech A & P Pte. Ltd. (“Primech A & P”) has successfully secured a series of new residential cleaning and waste management service contracts with a total estimated value of a ...
PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia
Globenewswire· 2026-02-26 13:26
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), announced that it has executed an agreement with Spaulding Rehabilitation (“Spaulding Rehabilitation”), a member of the Mass General Brigham healthcare system, for the provision of MDMA for use in a clinical trial investigating MDMA-assisted therapy for the trea ...
STEALTHGAS INC. Announces the Date for the Release of the Fourth Quarter and Twelve Months 2025 Financial and Operating Results, Conference Call and Webcast
Globenewswire· 2026-02-26 13:24
ATHENS, Greece, Feb. 26, 2026 (GLOBE NEWSWIRE) -- STEALTHGAS INC. (NASDAQ: GASS) (the “Company”), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today that it will release its fourth quarter operating and financial results for the period ended December 31, 2025 before the market opens in New York on March 2, 2026. On March 2, 2026 at 10:00 am ET, the company’s management will host a conference call to discuss the results and the compa ...
SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247
Globenewswire· 2026-02-26 13:23
Results from IV Phase 1 SAD/MAD Trial Expected in 2026JERSEY CITY, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the first participants have been dosed in a Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) trial evaluating the intravenous formulation (IV) of its second-generation triterpenoid antifungal therapy, S ...
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
Globenewswire· 2026-02-26 13:19
Physician Interview Now AvailableKey Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with the Company’s peer-reviewed randomized controlled trial.CMS Payment Rate: $300 national Medicare payment rate established, effective January 1, 2026.Physician Perspective: New interview with Gastroenterologist Dr. Dak Patel about inFoods IBS in clinical use now available at https: ...
Inuvo to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on Thursday, March 5th at 4:15 P.M. ET
Globenewswire· 2026-02-26 13:15
LITTLE ROCK, Ark., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leader in artificial intelligence-driven advertising technology, will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, March 5, 2026. The Company will host a conference call at 4:15 p.m. Eastern Time that same day to discuss the results and provide a business update. Conference Call Details: Date: Thursday, March 5, 2026Time: 4:15 p.m. Eastern T ...
Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposition Profile Versus Commercial Reference Product
Globenewswire· 2026-02-26 13:12
Raanana, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced results from a comparative study evaluating the regional nasal deposition profile of its naloxone formulation versus a commercial reference product. The study was conducted at the University of Parma’s Biopharmanet-TEC research center under the scientific supervision of Prof. Fabio Sonvico. T ...
Navigator Gas Announces Date for the Release of Fourth Quarter and Full Year 2025 Results and Zoom Conference Call
Globenewswire· 2026-02-26 13:05
LONDON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, announces today that it will release its results for the three and twelve months ended December 31, 2025, after markets close in New York, on Wednesday, March 11, 2026. The next day, Thursday, March 12, 2026, at 9:00 A.M. E.T., the Company’s management team will host a Zoom conference ca ...